- Shareholders Approve All Items -
LAKE FOREST, Ill., May 14 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2009 Annual Meeting of Shareholders in Denver, Colo. The agenda included votes on three items and an update on the company's five-year progress and its strategy going forward.
"We have made significant progress since becoming a public company in 2004, a testament to the strong foundation we have established and the disciplined execution of our strategies," said Christopher B. Begley, chairman and chief executive officer. "Our commitment to providing high quality, innovative solutions that meet customer needs, along with our increased focus on driving sustainable growth, position Hospira for continued success."
During the annual meeting, shareholders:
A full description of the above matters was included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's Web site at www.hospirainvestor.com, as are Begley's remarks made at today's meeting.
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.
|SOURCE Hospira, Inc.|
Copyright©2009 PR Newswire.
All rights reserved